Category: NxStage Medical Inc.Syndicate content

Press Release: NxStage announces FDA clearance of Single Needle Technology

September 18, 2014 by MassDevice

Innovative needle design to enhance patient safety.

Press Release: NxStage announces FDA clearance of Single Needle Technology

LAWRENCE, Mass. -- 

NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced its single needle technology, OneSite, has received FDA clearance.

NxStage Medical's single-needle home dialysis system comes to the U.S.

September 18, 2014 by Arezu Sarvestani

NxStage Medical wins FDA clearance to market its OneSite single needle dialysis technology for use with its portable systems.

NxStage Medical's single-needle home dialysis system comes to the U.S.

Massachusetts-based dialysis devices maker NxStage Medical (NSDQ:NXTM) won FDA clearance for its OneSite technology, cutting down on the number of needles dialysis patients must endure during therapy.

HeartWare nabs JenaValve exec Leadley for medical chief | Personnel Moves

August 12, 2014 by Brad Perriello

HeartWare International names Dr. Katrin Leadley to be its new chief medical officer following the retirement of Dr. David Hathaway.

HeartWare nabs JenaValve exec Leadley for medical chief | Personnel Moves

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

NxStage Medical tops Q4, 2013 estimates

February 27, 2014 by Brad Perriello

NxStage Medical beats expectations with its 4th-quarter and 2013 results, but investors send shares down anyway.

NxStage Medical tops Q4, 2013 estimates

NxStage Medical (NSDQ:NXTM) shares rose today after the medical device company said it just beat estimates with its results for the 4th quarter and last year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

NxStage launches dialysis patient outreach program

February 11, 2014 by Chris Walker

NxStage Medical campaigns to increase awareness of home hemodialysis with the NxStage System One.

NxStage begins patient outreach program

NxStage Medical (NSDQ:NXTM) launched a new patient outreach program called NxStage Plus One, through which it hopes to increase awareness of home hemodialysis with the NxStage System One.

NxStage Medical's Q4 prelims beat its own, Wall Street's forecasts

January 14, 2014 by Brad Perriello

NxStage Medical's shares are up today after the medical device company beats its own and Wall Street's expectations with its preliminary 4th-quarter sales numbers.

NxStage Medical's Q4 prelims beat its own, Wall Street's forecasts

NxStage Medical (NSDQ:NXTM) saw its stock price climb this morning after reporting preliminary 4th-quarter sales numbers that topped its own forecast and handily beat expectations on Wall Street.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp